30 posts on this topic, sorted most recent first.
Most coverage of tirzepatide treats it as a weight-loss drug. For T2D patients, the dose ramp, dosing goal, comparison frame, and what success looks like are all different.
Most first-visit conversations get rushed because the patient isn't prepared and the clinician has 12 minutes. Here's the prep list that makes the appointment actually useful.
Tirzepatide has been the most-asked-about drug in the Panya inbox for two years. Here's the entire blog catalog on it, organized by the question you're actually trying to answer.
Pen technique gets twenty seconds at the prescription appointment. The patient handouts say 'rotate sites'. There's more to it, and a few of the details affect whether week one is rough or smooth.
What customs actually cares about, how cold chain works in checked luggage, and the documentation that gets you through any border without a problem.
Lilly has redesigned the Mounjaro pen multiple times since 2023 and ships region-specific variants. Most pen-appearance changes are legitimate. The few that aren't matter.
Three telehealth operators (Juniper, Pilot, Mosh) plus LillyDirect's direct path. TGA September 2025 advertising enforcement reset the marketing landscape. Brand-pharmacy supply only · Australia doesn't have a US-style compounded GLP-1 market. Per-month pricing, what each operator actually offers, who fits where.
An afternoon in Sukhumvit, four clinics, the same five questions about Mounjaro at each one. The price quotes ranged from 6,000 to 14,500 baht for the same dose. The medical conversation ranged from 'sign here' to a 30-minute consult. Here's what I learned about how to actually choose.
A reader sent me a denial letter from her US insurer. They covered Wegovy. They didn't cover Mounjaro. Same patient, same diagnosis, same prescriber. The reason isn't medical. It's a contract that nobody mentions.
Eli Lilly launched Mounjaro in NZ February 2026 via Medsafe approval; private telehealth (Well Revolution + Pocket Lab) stocking from launch week. Wegovy still pending Medsafe filing. Foundayo (orforglipron) MHRA / EMA / Medsafe trajectory all 12-18 months behind FDA. What NZ readers can do today.
It's the most-asked question in the GLP-1 conversation and the answer most articles give is some version of 'tirzepatide loses more weight, choose tirzepatide if you can.' That's directionally true and practically incomplete. Here's the version that actually helps you decide.
MOH Circular 87/2024 hit its one-year anniversary in March; the in-person-consultation rule is now observable, not theoretical. Foundayo (orforglipron) HSA pathway tracking 12-18 months behind FDA. Oral Wegovy 25mg HSA filing the more imminent question. What changed for SG readers since the April buyer's guide.
What changed for UK GLP-1 access since the April 2026 buyer's guide. NHS QOF tirzepatide indicators went live April 1; Cohort 2 (BMI 35-39.9) starts June; oral Wegovy 25mg shipped at private pharmacies in January; Foundayo (orforglipron) MHRA pathway tracked. Private market still dominant. What to do today.
A reader sent me a DM at 11pm on a Sunday: appointment Monday morning, what do I actually need to ask? The list most people Google online is too long, vague, and written by someone who has never had a 15-minute appointment. Here's the shorter list that matters.
The patient handouts give you a list of possible side effects. They don't tell you the timeline. Here's the day-by-day version most clinics don't write down.
BPOM intermittency means the existing Bali buyers guide gets stale fast. This is the May 2026 supply-state tactical · per-clinic Mounjaro and Ozempic stocking, the most-current expat-routable picks, and the Bangkok-hop fallback when the nomad-clinic layer has gaps.
Bangkok is the regional anchor for legitimately-supplied tirzepatide and semaglutide in Southeast Asia. Flight matrices, clinic-relationship cadence, cold-chain transit, customs personal-use rules per origin country, and the four-versus-twelve-week supply math.
Weekly read on what's actually in stock at the Bangkok premium hospitals and mid-tier clinics, with price changes since last digest, regulatory movements that affect supply, and the picking question for this week. New format, weekly cadence, BKK-anchored. Issue 1.
HK Department of Health licenses Wegovy + Mounjaro for limited indications. Private clinic supply is steady but premium-priced. The 1h45 Bangkok flight is the cost-arbitrage many HK-resident expats end up using. What's actually licensed, per-clinic pricing, and the picking framework.
The Singapore GLP-1 clinic layer beyond the existing buyers guide. Per-clinic pricing for the four most-routable Singapore providers, MOH-licensed-product reality, the Wegovy-vs-Ozempic supply picture, and when the 2h20 Bangkok flight beats the local cost.
The dose-step decisions most people get wrong on tirzepatide. When to stay at 5mg, when to push to 10mg, what gastrointestinal side effects actually tell you, and the muscle-loss + protein math nobody mentions until it bites.
Side-by-side comparison of the three branded GLP-1 pens available in Bangkok in May 2026. Per-month USD pricing at premium hospitals and mid-tier clinics, supply state per medication, and the picking question once cost is on the table.
The four Bangkok premium hospitals scored on Panya's 11-signal rubric: Bumrungrad, Samitivej Sukhumvit, BNH, and BDMS Wellness Clinic. JCI accreditation, real GLP-1 menu depth, BDMS-group concentration, and how Thailand-resident expats actually pick.
BIMC Hospital, Body Tonic Clinic, Cocoon Medical Spa, Siloam, Kasih Ibu. USD pricing, BPOM posture post-2025 import tightening, and how nomads + expats actually pick a Bali GLP-1 provider.
Chi Longevity, The Longevity GP, Siena Health, Noah, Ordinary Folk, Clifford Clinic. SGD pricing, MOH 87/2024 in-person-first rule, what the 11-signal rubric scores them on, and how expats actually pick.
Metabolic.Health, Endocare, Zone.Health, DarDoc, Valeo, Limitless Human, Hortman, Novomed. AED pricing, DHA / DOH posture, Foundayo arrival, and how to pick the right Emirates GLP-1 route.
Numan, Voy, Juniper, Boots, Asda, Pharmacy2U, ZAVA, Second Nature. Per-dose pricing, MHRA posture, what the rubric scores them on, and how to pick the right one for your situation.
FV Hospital, Family Medical Practice, Raffles Medical, Vinmec. USD pricing, MoH posture, supply intermittency reality, and how expats actually pick a Vietnam GLP-1 provider.
The real differences between compounded tirzepatide from a 503A pharmacy and brand Mounjaro from Eli Lilly. Regulatory status, quality control, pricing, and when one is clearly better than the other.
Eight physical tells on a real Eli Lilly Mounjaro pen, what counterfeiters get wrong, and how to sanity-check a vial or pen from any source before you inject. Updated April 2026.